| Dietary factors and low-grade inflammation in relation to overweight and obesity PC Calder, N Ahluwalia, F Brouns, T Buetler, K Clement, K Cunningham, ... British Journal of Nutrition 106 (S3), S1-S78, 2011 | 1315 | 2011 |
| Vascular complications in diabetes mellitus: the role of endothelial dysfunction CG Schalkwijk, CDA Stehouwer Clinical science 109 (2), 143-159, 2005 | 946 | 2005 |
| Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension L Van Heerebeek, N Hamdani, ML Handoko, I Falcao-Pires, RJ Musters, ... Circulation 117 (1), 43-51, 2008 | 900 | 2008 |
| Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women AE Hak, CDA Stehouwer, ML Bots, KH Polderman, CG Schalkwijk, ... Arteriosclerosis, thrombosis, and vascular biology 19 (8), 1986-1991, 1999 | 754 | 1999 |
| Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk … N Verzijl, J DeGroot, CB Zaken, O Braun‐Benjamin, A Maroudas, ... Arthritis & Rheumatism 46 (1), 114-123, 2002 | 614 | 2002 |
| Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian J Krakoff, T Funahashi, CDA Stehouwer, CG Schalkwijk, S Tanaka, ... Diabetes care 26 (6), 1745-1751, 2003 | 481 | 2003 |
| Disease variants alter transcription factor levels and methylation of their binding sites MJ Bonder, R Luijk, DV Zhernakova, M Moed, P Deelen, M Vermaat, ... Nature genetics 49 (1), 131-138, 2017 | 472 | 2017 |
| Identification of context-dependent expression quantitative trait loci in whole blood DV Zhernakova, P Deelen, M Vermaat, M Van Iterson, M Van Galen, ... Nature genetics 49 (1), 139-145, 2017 | 459 | 2017 |
| Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications, and other age-related diseases CG Schalkwijk, CDA Stehouwer Physiological reviews 100 (1), 407-461, 2020 | 436 | 2020 |
| Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction … CG Schalkwijk, DCW Poland, W Van Dijk, A Kok, JJ Emeis, AM Dräger, ... Diabetologia 42, 351-357, 1999 | 433 | 1999 |
| Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes—the EURODIAB Prospective Complications … MT Schram, N Chaturvedi, CG Schalkwijk, JH Fuller, CDA Stehouwer, ... Diabetologia 48, 370-378, 2005 | 379 | 2005 |
| Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences MM Van Greevenbroek, CG Schalkwijk, CD Stehouwer Neth J Med 71 (4), 174-87, 2013 | 355 | 2013 |
| Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians C Weyer, JS Yudkin, CDA Stehouwer, CG Schalkwijk, RE Pratley, ... Atherosclerosis 161 (1), 233-242, 2002 | 351 | 2002 |
| The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases DEM Maessen, CDA Stehouwer, CG Schalkwijk Clinical science 128 (12), 839-861, 2015 | 338 | 2015 |
| Analysis of advanced glycation endproducts in selected food items by ultra-performance liquid chromatography tandem mass spectrometry: Presentation of a dietary AGE database JLJM Scheijen, E Clevers, L Engelen, PC Dagnelie, F Brouns, ... Food chemistry 190, 1145-1150, 2016 | 316 | 2016 |
| Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study JW Nin, A Jorsal, I Ferreira, CG Schalkwijk, MH Prins, HH Parving, ... Diabetes care 34 (2), 442-447, 2011 | 300 | 2011 |
| Effects of short‐term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo‐controlled trial J De Jager, A Kooy, PH Lehert, D Bets, MG Wulffele, T Teerlink, ... Journal of internal medicine 257 (1), 100-109, 2005 | 300 | 2005 |
| Advanced glycation end products and diabetic foot disease MSP Huijberts, NC Schaper, CG Schalkwijk Diabetes/metabolism research and reviews 24 (S1), S19-S24, 2008 | 296 | 2008 |
| Fructose‐mediated non‐enzymatic glycation: sweet coupling or bad modification CG Schalkwijk, CDA Stehouwer, VWM van Hinsbergh Diabetes/metabolism research and reviews 20 (5), 369-382, 2004 | 278 | 2004 |
| Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study MT Schram, N Chaturvedi, C Schalkwijk, F Giorgino, P Ebeling, JH Fuller, ... Diabetes care 26 (7), 2165-2173, 2003 | 278 | 2003 |
